A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer
Clinical trial NCT03343301 · COMPLETED
Trial details
- NCT number
- NCT03343301
- Sponsor
- Five Prime Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2019-01-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.